Dine out for a cause Monday ...
This expanded indication for Amvuttra makes it the first and only FDA-approved treatment for transthyretin amyloidosis with ...
The Food and Drug Administration (FDA) has approved Amvuttra ® (vutrisiran) for the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults to ...
Welcome back to TechCrunch Mobility — your central hub for news and insights on the future of transportation. Sign up here ...
Alnylam announced the FDA approval of its supplemental new drug application for vutrisiran, an RNA interfering small molecule ...
Alnylam's RNAi TTR Silencing Drug Amvuttra FDA Approved for Transthyretin Amyloidosis Cardiomyopathy
The drug was already sold for TTR amyloidosis with polyneuropathy, and now is available to patients with hereditary or wild-type ATTR-CM.
Along with tafamidis and acoramidis, the drug is now the third for ATTR-CM, but it comes with a whopping price tag of ...
The FDA has approved a supplemental new drug application for the treatment of cardiomyopathy wild-type or hereditary transthyretin-mediated amyloidosis.
The approval expands the indication for Amvuttra, which now becomes the first and only therapeutic approved by the FDA for ...
Now just under $1,000, this Asus TUF Gaming A15 is worth checking out. You'll get an AMD Ryzen 7 7735HS CPU, RTX 4050 GPU, ...
In terms of safety and tolerability, the most common adverse reactions in patients treated with Amvuttra were pain in ...
Unfortunately, since almost no one makes a new film camera these days, you have to settle for a used model if you want to try ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback